Applications are open! Become a 2025-26 Stanford Biodesign Innovation Fellow. Application link 👇🏾 #innovationeducation #healthtech
Stanford Byers Center for Biodesign
Higher Education
Stanford, California 14,534 followers
Educating the next generation of health technology innovators
About us
We are dedicated to advancing health outcomes and equity through innovation education, translation and policy. WELCOME TO THE FUTURE OF HEALTHCARE At Stanford Biodesign, we bring the world’s most promising minds into our circle to investigate, inspire, and innovate a healthier world for all. We offer a portfolio of educational programs to engage both aspiring and experienced innovators in the important challenge of reinventing health care with the help of technology. Each of our programs teaches our need-driven, value-based approach to health technology innovation and how to apply it to improve lives everywhere.
- Website
-
https://biodesign.stanford.edu/
External link for Stanford Byers Center for Biodesign
- Industry
- Higher Education
- Company size
- 11-50 employees
- Headquarters
- Stanford, California
- Type
- Educational
- Founded
- 2001
- Specialties
- Fellowships, Stanford Undergraduate Classes, Executive Education, Grants, Medicine, Biodesign, Technology, Medical Devices, Healthcare, Life Sciences, Policy, Global Education, Innovation, Design, Bioengineering, Stanford Medicine, equity, translation, diversity, and inclusion
Locations
-
Primary
318 Campus Dr E
Stanford, California 94305, US
Employees at Stanford Byers Center for Biodesign
Updates
-
🎙️Stanford Biodesign alumni in action! 2012-13 Innovation Fellow, John Paderi, is currently the chief scientific officer at IHP Therapeutics and Stanford Biodesign’s assistant director of biotechnology. Coming out of the fellowship, he co-founded Symic Bio: a startup that developed a drug for enhancing the success and safety of vascular interventions for individuals with atherosclerosis. Listen to this insightful episode of the Cell, Culture, Community podcast, where he discusses how he is applying his biodesign training in developing a novel, self-administered drug to alleviate sickle cell disease (SCD) pain crises. Thank you Smiti Mittal for the opportunity to share evidence of how our fellows are impacting the world of biotechnology!
Over 90% of American #SickleCellDisease (SCD) patients are Black or African American, contributing to a history of #underfunding and stigma. Patients (even children) in severe pain are often misconstrued as drug-seekers. I spoke with John Paderi, who recognised from his training at the Stanford Byers Center for Biodesign that the future of sickle cell pain management should empower patients by moving care into the home setting. He's developing an accessible, self-administered drug at IHP Therapeutics. Tune in to hear about why #opioids are inadequate, how IHP developed their new molecule, and his experience as #ChiefScientificOfficer — risks, opportunities, and strategy. We also explore how he integrates Biodesign with his #academia training, surprising parallels between SCD and #migraines, and his most rewarding moment at IHP so far! https://lnkd.in/g_ZVfHsq
-
📌Reminder: Applications for the 2025-26 Innovation Fellowship close at 11:59 pm PT next Friday August 9. If you missed the Q&A session with some of our international alumni, check out the recording here: https://lnkd.in/gSPdM94b
Biodesign Innovation Fellowship - International Application
https://www.youtube.com/
-
🟢 We are less than a week away from receiving our newest cohort of Innovation and Policy Fellows! Biodesign community: What advice would you give the incoming fellows? Leave us your ideas in the comments ⤵️. 📷P.S. Fellows, the Stanford Biodesign staff and faculty can’t wait to see you soon! #biodesign #fellowship #innovationeducation #healthtech
-
-
“I enjoyed working on HrtEx, I'm really passionate about how software design decisions can solve different problems. In the health space, it can be challenging to design a clinical decision support algorithm that works in all cases, because healthcare data is complex and often unstructured.” Nikolai Madlener is a computer science graduate student from the Technical University of Munich who joined Stanford Biodesign Digital Health as a visiting researcher focused on developing a clinical decision support system for hypertension management and contributing to the Stanford Spezi open-source ecosystem. Since March, he has been working on improving HrtEx: a customizable platform that provides doctors with recommendations of medications for their hypertension patients based on their blood pressure values and complete clinical profile. Nikolai’s involvement in this project, lead by Prof. Vivek Bhalla and Prof. Paul J. Wang, was key to redesigning the way this web application allows doctors to modify the rules that the program follows to match the patient with a predefined dosage. HrtEx is based on a Biodesign Faculty Fellow project by Prof. Paul Wang and is funded by Stanford Medicine Catalyst. Over the coming months, Nikolai will be focusing on finishing his master’s thesis back at Munich, continuing to be involved in HrtEx, while the research team gets the project ready for clinical trials. We enjoyed having you here Nikolai! Auf wiedersehen! CC: Stanford Medicine Catalyst https://lnkd.in/gkRP6MR #healthapp #digital #biodesign
-
-
Back in 2007 when we launched Stanford India Biodesign (SIB), our first global collaboration, together with the All India Institute of Medical Sciences (AIIMS) and the Indian Institute of Technology (IIT) Delhi, we could not have imagined how much we would learn from the program, the remarkable impact it would have in India, and how it would influence our subsequent partnerships in other countries. 🇮🇳 Our dear friend Prof. MK Bhan, a true visionary who was then Secretary of Biotechnology, Government of India, was instrumental in creating this first-of-its-kind partnership. Founding team members, Drs. Balram Bhargava, Anurag Mairal, PhD, and Rajiv Doshi, MD reconnected this past weekend together with Stanford Biodesign’s director emeritus Paul Yock! SIB transitioned to independent status as the School of International Biodesign after nine years. Anurag and Rajiv continue to lead other Stanford Biodesign India programs including the Founder’s Forum, an executive education program for India’s top healthtech start-up innovators (the most recent session was hosted in Bangalore earlier this month), and an Edwards Lifesciences Foundation-funded initiative to combat rheumatic heart disease. Dr. Bhargava would later serve as director general of the Indian Council of Medical Research and continues to advise large and small health technology and pharma companies in India. The ecosystem created by these India Biodesign programs continues to impact hundreds of millions of patients in India and beyond! #TBT #historylesson #reunion #globalbiodesign #healthtech #medtech
-
-
💊“We hope our solution will greatly increase screening versus colonoscopy, so that deadly colorectal cancer can be detected in its earliest stages and lives can be saved.” As part of their Bioengineering Senior Capstone Design course, Kelly Lopez-Cid, Shreya Garg, and Gabe Eduardo Seir focused on finding a way to increase screening compliance for colorectal cancer, the second leading cause of cancer death in the US among cancers that affect both men and women. The ColoTech team’s concept is a less invasive solution: a pill to detect early-stage cancer through the emission of fluorescence signals. Read more about their project: https://lnkd.in/eq4HGATn
ColoTech: An Early-Stage Colorectal Cancer Detection Method that is Easy to Swallow
biodesign.stanford.edu
-
Stanford Biodesign director emeritus Paul Yock, MD and biotechnology director, D. Michael Ackermann, were among the speakers at last week’s Ophthalmic Innovation Symposium hosted by the Byers Eye Institute at Stanford. Centered on the theme, "From Concept to Clinic”, they shared their expert perspectives on innovation and how to effectively translate an idea into patient care. 💡Fun fact: Michael, a 2010-11 alumnus of the Innovation Fellowship, has founded multiple companies in the ophthalmology space—his very first, Occuleve, acquired by Allergan, was based on his fellowship project. #innovationeducation #healthtech #ophthalmology
-
-
Many thanks to our alumni fellows Nathaniel G. George, Anastasia Ntracha, Ignacio Pérez, Marta Arenas-Jal, PhD, and Cyan Brown, MD, MPH for their time and amazing insights! Here are some highlights from the discussion 👇 The recording will be available on our website next week: https://lnkd.in/gyAyPJTv If you have any questions regarding the application process, please contact our Fellowships Manager, Meghan Stawitcke (meghans4@stanford.edu). #biodesign #fellowship #innovation
-
🟢LIVE NOW! Join five of our Innovation Fellowship alumni as they discuss their experiences in the fellowship as international trainees: what worked well, what they learned, and what surprised them along the way. Update: The webinar recording will be available next week on our website: biodesign.stanford.edu
-